Sorted By Test Name - Mayo Medical Laboratories

SEUR
60077
Teratogenic effects are frequently noted in the offspring of animals living in regions where soil content is
high in selenium such as south-central South Dakota and northern-coastal regions of California. Selenium
toxicity in humans is not known to be a significant problem except in acute overdose cases. Selenium is
not classified as a human teratogen. Selenium is found in many over-the-counter vitamin preparations
because its antioxidant activity is thought to be anticarcinogenic. There is no supporting evidence that
selenium suppresses cancer. Urine quantitation is used to assess clearance and in balance studies.
Useful For: Monitoring selenium replacement therapy
Interpretation: The normal daily intake of selenium is 10 mcg/day to 35 mcg/day; therefore, the usual
daily output should be the same. Daily excretion of 35 mcg/24
hour indicates excessive intake. There is no known toxicity to humans due to intake of modest excesses.
Grossly excessive intake (daily output >500 mcg/24 hours) may have a teratogenic impact. This effect has
been demonstrated in animals.
Reference Values:
0-15 years: not established
> or =16 years: 10-35 mcg/specimen
Clinical References: 1. Fleming CR, McCall JT, O'Brien JF, et al: Selenium status in patients
receiving home parenteral nutrition. J Parenter Enteral Nutr 1984;8:258-262 2. Chariot P, Bignani O:
Skeletal muscle disorders associated with selenium deficiency in humans. Muscle Nerve 2003
Jun;27(6):662-668 3. Kvicala J, Zamrazil V, Nemecek J, et al: Intake of selenium by seniors of South
Bohemia and urine selenium of seniors in the course of a 1-year supplementation by various selenium
species. Trace Elements and Electrolytes 2008;25:21-24
Selenium, Random, Urine
Clinical Information: Selenium is an essential element. It is a cofactor required to maintain
glutathione peroxidase (GSH-Px) activity, an enzyme that catalyzes the degradation of organic
hydroperoxides. The absence of selenium correlates with loss of GSH-Px activity and is associated with
damage to cell membranes due to accumulation of free radicals. In humans, cardiac muscle is the most
susceptible to selenium deficiency. With cell membrane damage, normal cells are replaced by fibroblasts.
This condition is known as cardiomyopathy and is characterized by an enlarged heart whose muscle is
largely replaced by fibrous tissue. In the United States, deficiency is related to use of total parenteral
nutrition. This is therapy administered to patients with no functional bowel, such as after surgical removal
of the small and large intestine because of cancer, or because of acute inflammatory bowel disease such as
Crohn's disease. Selenium supplementation to raise serum concentration >90 ng/mL is the usual
treatment. Serum monitoring done on a semi-annual basis checks the adequacy of supplementation.
Selenium toxicity has been observed in animals when daily intake exceeds 4 parts per million (ppm).
Teratogenic effects are frequently noted in the offspring of animals living in regions where soil content is
high in selenium such as south-central South Dakota and northern-coastal regions of California. Selenium
toxicity in humans is not known to be a significant problem except in acute overdose cases. Selenium is
not classified as a human teratogen. Selenium is found in many over-the-counter vitamin preparations
because its antioxidant activity is thought to be anticarcinogenic. There is no supporting evidence that
selenium suppresses cancer. Urine quantitation is used to assess clearance and in balance studies.
Useful For: Monitoring selenium replacement therapy
Interpretation: The normal daily intake of selenium is 10 mcg/day to 35 mcg/day, therefore, the usual
daily output should be the same. Daily excretion of 50 mcg/L indicates
excessive intake. There is no known toxicity to humans due to intake of modest excesses. Grossly
excessive intake (daily output >500 mcg/L) may have a teratogenic impact. This effect has been
demonstrated in animals.
Reference Values:
0-15 years: not established
Current as of January 4, 2013 7:15 pm CST 800-533-1710 or 507-266-5700 or MayoMedicalLaboratories.com Page 1568